Summary: Drs Chet Rihal and Kevin Greason share Mayo Clinic's expertise in transcatheter aortic-valve replacement with insight intended for centers embarking on new programs. Among topics, they discuss: the key determinants of prognosis, the learning curve, addressing the risk of perioperative stroke, appropriate antiplatelet and anticoagulant therapies, access sites, and the importance of the "preflight check list."
